Xact Kapitalforvaltning’s Vanda Pharmaceuticals VNDA Stock Holding History

Xact Kapitalforvaltning’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$131K	Hold	12,600	–	–	﹤0.01%	1263
2019 Q4	$207K	Hold	12,600	–	–	﹤0.01%	1376
2019 Q3	$167K	Hold	12,600	–	–	﹤0.01%	1391
2019 Q2	$178K	Hold	12,600	–	–	﹤0.01%	1399
2019 Q1	$232K	Hold	12,600	–	–	0.01%	1344
2018 Q4	$329K	Hold	12,600	–	–	0.01%	1174
2018 Q3	$289K	Hold	12,600	–	–	0.01%	1385
2018 Q2	$240K	Buy	+12,600	New	+$211K	0.01%	1479

Other funds holding VNDA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Xact Kapitalforvaltning's VNDA Position: Q1 2020 in Review

Xact Kapitalforvaltning held its Vanda Pharmaceuticals (VNDA) position steady in Q1 2020 at 12,600 shares worth $131K. The position accounts for ﹤0.01% of the portfolio, ranked #1263.

Xact Kapitalforvaltning first reported a position in VNDA in Q2 2018 and has held it in 8 quarters since. The position peaked at $329K in Q4 2018. 159 funds tracked by Wall St. Rank hold VNDA as of Q1 2020.

Xact Kapitalforvaltning held 12,600 shares of Vanda Pharmaceuticals worth $131K as of Q1 2020.
Xact Kapitalforvaltning left its Vanda Pharmaceuticals share count unchanged in Q1 2020.
Vanda Pharmaceuticals made up ﹤0.01% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #1263 holding.
Xact Kapitalforvaltning first reported a position in Vanda Pharmaceuticals in Q2 2018 and has held it in 8 quarters since.
Xact Kapitalforvaltning's Vanda Pharmaceuticals position peaked at $329K in Q4 2018.
159 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.